Clinical Trial

Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Cerebral venous disorders, including cerebral venous sinus stenosis (CVSS) and cerebral venous sinus thrombosis (CVST), can obstruct venous blood drainage, leading to intracranial hypertension. However, their effects on glymphatic function and white matter integrity in the brain remain poorly understood. Therefore, this study will enroll healthy controls, CVSS patients, and CVST patients to compare differences in glymphatic function and white matter microstructural integrity. Additionally, CVSS and CVST patients will undergo a 3-month follow-up to investigate the interrelationships and longitudinal changes among clinical parameters, glymphatic function, and white matter integrity.
Trial Details
NCT Number NCT07072663
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Cerebral Venous Sinus Thrombosis
Enrollment 149 participants
Start Date 2025-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-07-18